| Q36411170 | Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analyses |
| Q47149942 | Chinese Guideline on allergen immunotherapy for allergic rhinitis |
| Q44146733 | Clinico-immunologic study on immunotherapy with mixed and single insect allergens |
| Q37427490 | Current immunological approaches for management of allergic rhinitis and bronchial asthma |
| Q33831562 | Current specific immunotherapy for allergic rhinitis: perspectives from otorhinolaryngologists |
| Q30415158 | Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis |
| Q36791729 | Economic evaluation of 5-grass pollen tablets versus placebo in the treatment of allergic rhinitis in adults |
| Q38073718 | New directions in immunotherapy. |
| Q60910190 | Parietaria Allergy: An Intriguing Challenge for the Allergist |
| Q91879360 | Patient characteristics in German allergological practices - a nationwide survey |
| Q37684339 | Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis |
| Q84564227 | Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis |
| Q37140039 | Sublingual immunotherapy and allergic rhinitis |
| Q36994648 | Sublingual immunotherapy in pediatric allergic rhinitis and asthma: efficacy, safety, and practical considerations |
| Q42716940 | Trends in Specific Immunotherapy for Allergic Rhinitis: A Survey of Chinese ENT Specialists |